Obesity Therapy
Weight loss produced by orlistat reduced the incidence of diabetes
Published in Obesity and Diabetes Week, March 20th, 2006
"The current obesity pandemic imposes a major global disease burden. However, sustained weight loss of between 5 and 10% in the obese confers marked health benefits," a scientist in England reported.
"Currently available pharmacotherapies, orlistat and sibutramine, can induce weight loss of between 5 and 10% over 2 years or more. However, in these trials, drug induced weight loss tends to be only 2-4 kg greater than that produced by placebo control," wrote J.C.G. Halford, University of Liverpool.
The investigator found, "Despite this, in the XENDOS...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Complementary & Alternative Medicine
Chromium supplement enhances cellular insulin signaling in obese insulin-resistant rats - Geriatrics
Weight loss improves the health of elderly with type 2 diabetes mellitus - Insulin Resistance
Adiponectin linked to insulin sensitivity independent of visceral adipose tissue - Obesity Epidemiology
Leptin receptor gene polymorphisms linked to obesity and type 2 diabetes mellitus - Adverse Drug Reaction
Valproate lowers glucose and raises insulin, cortisol, leptin, and neuropeptide Y levels - Anesthesia
Succinylcholine dose of 1 mg/kg total body weight is recommended for morbidly obese - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
